Company profile: Alliance for Multispecialty Research
1.1 - Company Overview
Company description
- Provider of multispecialty clinical research services, conducting all phases of clinical trials for biopharmaceutical and medical device development. Services include vaccine research (COVID-19, RSV), studies across cardiology, dermatology, endocrinology, internal medicine, orthopedics, pulmonology, and women's health; patient recruitment; advanced imaging and diagnostics; and controlled substance research.
Products and services
- Clinical Trials: Orchestrates all phases of clinical research for biopharmaceutical and medical device companies developing new drugs, devices, and diagnostics
- Multi-phase
- Patient Recruitment: Delivers dedicated patient recruitment services ensuring rapid enrollment and superior subject retention for clinical trials
- Rapid-enrollment
- Therapeutic Area Research: Conducts research across Cardiology, Dermatology, Endocrinology, Internal Medicine, Orthopedics, Pulmonology, and Women’s Health indications to expand investigational breadth
- Multi-therapeutic
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Alliance for Multispecialty Research
M2i Life Sciences
HQ: France
Website
- Description: Provider of custom synthesis and formulation of niche healthcare products (mainly generics), with activities in veterinary art, biological crop protection, and organic electronics. Offers redesign of synthetic routes for hard-to-make molecules, analytical services (method development, physico-chemical characterization, diffusion/stability studies), access to high-tech analytical equipment, and the Lobesia Pro Spray.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full M2i Life Sciences company profile →
ProSciento
HQ: United States
Website
- Description: Provider of clinical research and development services, leveraging broad scientific expertise, direct patient access, advanced methodologies, and integrated operations to advance science and achieve quality results through client and partner connections.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ProSciento company profile →
Benten Bio
HQ: United States
Website
- Description: Provider of regulatory-compliant manufacturing and testing services to support the development and commercialization of biopharmaceutical products. Offerings include biosafety testing, raw materials testing, assay and process validation services. A contract services organization focused on biological testing and biomanufacturing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Benten Bio company profile →
Synerlab
HQ: France
Website
- Description: Provider of contract development and manufacturing for medicinal products (human and veterinary), medical devices and food supplements, from product development to manufacturing and packaging across solid and semi-solid forms and non-sterile/sterile liquids. Services include formulation, galenics, analytics, clinical batches (phase 1–3), production of oral solids, non-sterile monodose, sterile multidose (nasal/eye/ear drops), and freeze drying, including biomolecular drugs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Synerlab company profile →
QPS
HQ: United States
Website
- Description: Provider of GLP/GCP-compliant contract research services spanning discovery, preclinical and clinical drug development, including neuropharmacology, DMPK, toxicology, bioanalysis, translational medicine, and clinical development support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full QPS company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Alliance for Multispecialty Research
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Alliance for Multispecialty Research
2.2 - Growth funds investing in similar companies to Alliance for Multispecialty Research
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Alliance for Multispecialty Research
4.2 - Public trading comparable groups for Alliance for Multispecialty Research
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →